Risks and Benefits of Interferon-α in the Treatment of Hepatitis
Authors:
- 1 November 1995
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 13 (5) , 304-316
Abstract
The high worldwide prevalence of chronic viral hepatitis, as well as its progressive course, have led to the performance of multiple clinical studies. The natural history of the disease is different...Keywords
This publication has 96 references indexed in Scilit:
- The Use of Interferon-α in Virus InfectionsDrugs, 1991
- Role of hepatitis delta virus infection in hepatocellular carcinomaDigestive Diseases and Sciences, 1991
- Hepatitis B: global importance and need for controlVaccine, 1990
- Treatment of chronic hepatitis B with interferon alfa-2bJournal of Hepatology, 1990
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989
- Treatment of chronic delta infection with recombinant human interferon alpha 2c at high dosesJournal of Hepatology, 1989
- Natural course after the development of cirrhosis in patients with chronic type B hepatitis: a prospective studyLiver International, 1989
- Chronic non‐A, non‐B hepatitis developed after transfusions, illicit self‐injections or sporadically. Outcome during long‐term follow‐up – a comparisonLiver International, 1989
- Treatment of Chronic Non-A, Non-B Hepatitis with Recombinant Human Alpha InterferonNew England Journal of Medicine, 1986